These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2453804)

  • 1. Conformational changes associated with ion permeation in L-type calcium channels.
    Pietrobon D; Prod'hom B; Hess P
    Nature; 1988 May; 333(6171):373-6. PubMed ID: 2453804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct measurement of proton transfer rates to a group controlling the dihydropyridine-sensitive Ca2+ channel.
    Prod'hom B; Pietrobon D; Hess P
    Nature; 1987 Sep 17-23; 329(6136):243-6. PubMed ID: 2442620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.
    Hu H; Marban E
    Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ permeation in cyclic nucleotide-gated channels.
    Dzeja C; Hagen V; Kaupp UB; Frings S
    EMBO J; 1999 Jan; 18(1):131-44. PubMed ID: 9878057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeation in the dihydropyridine-sensitive calcium channel. Multi-ion occupancy but no anomalous mole-fraction effect between Ba2+ and Ca2+.
    Yue DT; Marban E
    J Gen Physiol; 1990 May; 95(5):911-39. PubMed ID: 2163433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion interaction at the pore of Lc-type Ca2+ channel is sufficient to mediate depolarization-induced exocytosis.
    Lerner I; Trus M; Cohen R; Yizhar O; Nussinovitch I; Atlas D
    J Neurochem; 2006 Apr; 97(1):116-27. PubMed ID: 16515555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.
    Zhorov BS; Folkman EV; Ananthanarayanan VS
    Arch Biochem Biophys; 2001 Sep; 393(1):22-41. PubMed ID: 11516158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
    Peterson BZ; Catterall WA
    Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in conformation of plasma membrane phospholipid scramblase induced by occupancy of its Ca2+ binding site.
    Stout JG; Zhou Q; Wiedmer T; Sims PJ
    Biochemistry; 1998 Oct; 37(42):14860-6. PubMed ID: 9778361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
    Lacinová L; An RH; Xia J; Ito H; Klugbauer N; Triggle D; Hofmann F; Kass RS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1472-9. PubMed ID: 10336541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeable ions differentially affect gating kinetics and unitary conductance of L-type calcium channels.
    Hui K; Gardzinski P; Sun HS; Backx PH; Feng ZP
    Biochem Biophys Res Commun; 2005 Dec; 338(2):783-92. PubMed ID: 16243294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium ion channels in the cell membrane].
    Kostiuk PG
    Fiziol Zh SSSR Im I M Sechenova; 1984 Aug; 70(8):1081-91. PubMed ID: 6094263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
    Bangalore R; Baindur N; Rutledge A; Triggle DJ; Kass RS
    Mol Pharmacol; 1994 Oct; 46(4):660-6. PubMed ID: 7969044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists.
    Mlinar B; Enyeart JJ
    Mol Pharmacol; 1994 Oct; 46(4):743-9. PubMed ID: 7969054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of protons with single open L-type calcium channels. Location of protonation site and dependence of proton-induced current fluctuations on concentration and species of permeant ion.
    Prod'hom B; Pietrobon D; Hess P
    J Gen Physiol; 1989 Jul; 94(1):23-42. PubMed ID: 2553858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinetic pattern of a model of a calcium channel with 2 conformational states].
    Kostiuk PG; Mironov SL
    Neirofiziologiia; 1986; 18(5):705-7. PubMed ID: 2430202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of interaction of permeant ions and protons with dihydropyridine-sensitive calcium channels.
    Hess P; Prod'Hom B; Pietrobon D
    Ann N Y Acad Sci; 1989; 560():80-93. PubMed ID: 2545152
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of ion permeation through calcium channels.
    Hess P; Tsien RW
    Nature; 1984 May 31-Jun 6; 309(5967):453-6. PubMed ID: 6328315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.